FDA Inspection
Panacea Biotec Pharma LimitedPanacea Biotec Pharma Limited – FDA Inspection, Jun 8, 2022
Record Details
This FDA Inspection record concerns Panacea Biotec Pharma Limited, with an inspection on June 8, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 8, 2022
- Product Type
- Drugs
View Company Profile
ID · 1ac027f2-1327-483d-92c6-2cced3018ab7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1172929
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Panacea Biotec Pharma Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| October 12, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| April 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 13, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Panacea Biotec Pharma Limited
- FDA Inspection 1220156 - 2023-10-12
- FDA Inspection 1099402 - 2019-08-09
- FDA Inspection 1093361 - 2019-04-30
- FDA Inspection 1035804 - 2017-12-13
- FDA Inspection 954394 - 2015-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.